The 20 Best Prostate Cancer Doctors Near Me in Ann Arbor, MI

Dr. Vaishampayan is the Director of the Phase I program at the Rogel Cancer Center, University of Michigan, Ann Arbor MI. Dr. Vaishampayan is a Professor of Internal Medicine and her research is primarily in translational drug development and early phase clinical trials in cancer with a focus on genitourinary malignancies. She has initiated, obtained funding for, and conducted and published many investigator initiated trials with embedded biomarkers and established multidisciplinary collaboration. She has served as site PI of the UO-1 Early Therapeutics Research Grant at Wayne State University. She was also the chair of the solid tumor division of oncology at WSU. She has completed formal leadership traning course and is Fellow of the Advisory Board (FAB). She is the appointed chair of the Advanced Renal committee of SWOG and a member of the Renal task force of the NCI. She is a board member of the Michigan Society of Hematology/Oncology (MSHO) and organizes annual board review course. Additionally, she has served as track leader for the ASCO education committee GU non prostate (Renal and bladder cancer) track. Dr. Vaishampayan attended Wayne State University for her residency and fellowship completion and attended medical school at Byramjee Jeejeebhoy in Pune, India and completed a higher secondary certificate in the field of science at Fergusson College in Pune, India.In her free time, Dr. Vaishampayan enjoys reading, dance, music and travel. Travel, reading (mysteries preferred), follows football. Dr. Vaishampayan is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. She is also highly rated in 36 other conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Vaishampayan is board certified in Medical Oncology.

Ganesh S. Palapattu, MD, FACS is The George F. and Sandy G. Valassis Professor and Chair of the Department of Urology. He joined the University of Michigan Department of Urology as Associate Professor and Chief of Urologic Oncology in the Fall of 2012. Prior to this he was the Chief of Urologic Oncology at Houston Methodist Hospital in Houston, Texas. Dr. Palapattu has held faculty appointments at the University of Rochester School of Medicine in Rochester, NY where he was also Assistant Residency Program Director and Weill Cornell Medical College/The Houston Methodist Hospital.Dr. Palapattu was born in Toronto, Canada where he developed a passion for street hockey. At the age of 9, his family moved to Houston, Texas where he picked up playing the French horn. Dr. Palapattu graduated from the University of Texas at Austin with a B.A. degree in the Humanities and subsequently attended Baylor College of Medicine. Dr. Palapattu received his surgical/urological training at the David Geffen School of Medicine at UCLA and further specialty training in urologic oncology at Johns Hopkins. He and his wife, Anu, whom he met at UT Austin, have 2 young children. The Palapattu family is enthusiastic about taking advantage of the many outdoor activities the Ann Arbor area affords.When not working, Dr. Palapattu enjoys spending time with his family, traveling and playing/watching sports. Go Blue!. Dr. Palapattu is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Nephrectomy, and Prostatectomy. Dr. Palapattu is board certified in Urology.

Dr. Dess is an Associate Professor in the Department of Radiation Oncology at the University of Michigan.He attended medical school at University of Chicago and completed his residency in radiation oncology at the University of Michigan.He practices in several locations. At the University of Michigan Ann Arbor main campus, he is the co-Chief of Genitourinary Radiotherapy Service, and also leads the high dose rate (HDR) prostate brachytherapy program. At the Brighton Center for Specialty Care, he serves as the primary genitourinary radiation oncologist.Dr. Dess is a clinical and translational researcher focused on genitourinary malignancy. He has worked with a global network of collaborators to create novel prognostic models to characterize prostate cancer disease aggressiveness, to identify novel prognostic and predictive biomarkers, to analyze racial outcomes differences and settings in which disparities are minimized, and to advance more convenient forms of treatment including stereotactic body radiation therapy (SBRT) and high-dose rate brachytherapy (HDR). He is interested in maximizing efficacy, minimizing burden, and understanding the long-term toxicity risks of treatment. His work has been published high profile in peer-reviewed journals including the New England Journal of Medicine, Journal of Clinical Oncology, and JAMA Oncology.Dr. Dess also serves as the co-lead for prostate cancer within the Michigan Radiation Oncology Quality Consortium (MROQC) where he works to improve state-wide care. Dr. Dess is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and Prostatectomy. Dr. Dess is board certified in Radiation Oncology.

Todd M. Morgan, M.D. is a urological surgeon specializing in the treatment of genitourinary malignancies. Dr. Morgan is originally from Seattle, WA, and completed his undergraduate and medical training at Harvard University. He returned to the Northwest in 2003 for his urology residency at the University of Washington, before moving to Nashville for his fellowship training in urological oncology at Vanderbilt University. Dr. Morgan is a translational surgeon-scientist, and his research spans the spectrum from preclinical laboratory-based research to prospective clinical trials. The primary focus of his laboratory is on identifying key pathways that predict response and resistance to treatment in genitourinary malignancies. This includes work in prostate cancer to develop liquid biopsy approaches that can guide precision-based therapeutic strategies in real time, as well as ongoing research in renal cell carcinoma to identify genomic signatures for risk stratification.Dr. Morgan is currently an Associate Professor of Urology and has been at the University of Michigan since 2012. In addition to his research pursuits, he is a busy clinician and surgeon offering advanced robotic, laparoscopic, and open surgical approaches for patients with genitourinary malignancies. He has substantial expertise in the use and interpretation of molecular biomarkers, which can help guide individualized treatment choice for some patients.Beyond work, he loves his time enjoying the great town of Ann Arbor and beautiful state of Michigan with his wife, Wendy, and their two young boys. Whether camping in Petoskey, sitting on a beach in Grand Haven, or biking around the neighborhood in Ann Arbor, the Morgan family has quickly learned that life in the Midwest is hard to beat. Dr. Morgan is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Muscle Invasive Bladder Cancer, Bladder Cancer, Prostatectomy, and Nephrectomy. Dr. Morgan is board certified in Urology.

Simpa S. Salami, M.D., M.P.H. is a fellowship-trained, board-certified Urologic Oncologist and Associate Professor of Urology at the University of Michigan. He obtained his medical degree from the College of Medicine, University of Ibadan, Nigeria. Thereafter, he completed a Master of Public Health program at Harvard University, General Surgery Internship at the Brigham and Women’s Hospital in Boston, Urology Residency at Hofstra Northwell Health School of Medicine in New York, and Urologic Oncology Fellowship at the University of Michigan in Ann Arbor, Michigan. Dr. Salami’s clinical expertise is in the minimally invasive surgical treatment of prostate and kidney cancer. As a translational surgeon-scientist, his laboratory focuses on developing novel cancer biomarkers to overcome tumor heterogeneity and multifocality as well as elucidate optimal paradigms for early detection of urologic cancers, risk stratification, prognostication, and prediction of treatment response. Dr. Salami’s lab collaborates with investigators all over the world to understand the molecular underpinnings of urologic cancer and associated disparities. Dr. Salami is a recipient of several awards including the: Harvard University Presidential Scholar, Prostate Cancer Foundation Young Investigator, American Urological Association (AUA) Urology Care Foundation (UCF) Research Scholar, AUA UCF Rising Stars in Urologic Research, Harold Amos Medical Faculty Development Fellowship, Rogel Cancer Center Scholar, Society of Urologic Oncology Young Investigator, NCI R37 MERIT and 2024 AUA Gold Cystoscope Awards. Most recently, he was named an inaugural Biden White House Cancer Moonshot Scholar. He has served on several National guideline committees, such as the AUA Prostate Cancer Early Detection Guidelines, the NCCN Prostate Cancer Early Detection Guidelines, and the Society of Nuclear Medicine and Imaging PSMA PET Appropriate Use Criteria Working Group. His research is supported by multiple sources and includes funding from the Department of Defense, National Cancer Institute, and the Prostate Cancer Foundation. Dr. Salami is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Nephrectomy, and Prostatectomy. Dr. Salami is board certified in Urology.

Zachery Reichert is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Reichert is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Urothelial Cancer, Bladder Cancer, and Prostatectomy.

Dr. David Smith is a Professor of Internal Medicine and Urology at the University of Michigan and currently serves as the Associate Chief Clinical Officer for Cancer at Michigan Medicine and the Chief Medical Officer of the Rogel Cancer Center. Throughout his career he has focused on caring for patients with urologic cancers, cancer clinical trials, and the delivery of cancer care. Dr. Smith is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Testicular Cancer, Familial Prostate Cancer, Orchiectomy, and Prostatectomy.

Dr. Jeffery Montgomery's clinical interests include the diagnosis and management of bladder, prostate, and penile and testicular cancers. With his advanced training in urologic oncology and minimally invasive surgical techniques, such as robotic, laparoscopic and complex open surgery, he is able to deliver state-of-the-art care to his patients. He has expertise in state-of-the-art diagnostics for prostate cancer, including prostate MRI, fusion prostate biopsy, and transperineal standard and fusion prostate biopsies. He has extensive experience performing advanced robotic surgery, including prostatectomy, cystectomy with intra-corporeal urinary diversions, and inguinal lymph node dissections. Dr. Montgomery's research focuses on improving the quality and efficiency of urologic oncology disease management. Dr. Montgomery is a Michigan native and earned his undergraduate degree from the University of Michigan. He then went on to complete his medical education at the Columbia University College of Physicians and Surgeons in New York before finishing his Urology residency at the University of Michigan. He completed his urologic oncology fellowship at the University of Texas MD Anderson Cancer Center. Dr. Montgomery is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, Cystectomy, and Prostatectomy. Dr. Montgomery is board certified in Urology.

Ajjai Alva is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Alva is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Renal Cell Carcinoma (RCC), Bladder Cancer, Nephrectomy, and Lymphadenectomy.

Brent K. Hollenbeck, M.D., M.S. is a practicing urologic oncologist and has been on faculty at the University of Michigan since 2003. A graduate of the Indiana University School of Medicine, Dr. Hollenbeck completed his residency in urology and fellowship training in oncology at the University of Michigan. During the past 5 years, his clinical practice has grown in patient volume, which complements his research imperative. Over this time, he has become increasingly specialized in the care of patients with prostate and bladder cancers. This focus has afforded him the ability to maintain his commitment to research while continuing to deliver cutting-edge, high quality care.Dr. Hollenbeck is currently an Associate Professor of Urology and the Director of the Herbert H. and Grace A. Dow Division of Health Services Research at the University of Michigan. He is firmly committed to training the future leaders in urologic health services research. Further, he strongly believes that populating the surgical specialties with health services researchers will yield long-term benefits to both our specialty and our patients.When he is not engaged in clinical and research pursuits, Brent is a very active swimmer, runner and fly fisherman (especially for steelhead). Perhaps most importantly, however, he enjoys spending the bulk of his free time with his wife and two daughters. The Hollenbecks are avid fans of Michigan athletics and look forward to cheering on the Wolverines on football Saturdays. Dr. Hollenbeck is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Cystectomy.

Lindsey Herrel is a Urologist practicing medicine in Ann Arbor, Michigan. Dr. Herrel is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Vasectomy, and Nephrectomy. Dr. Herrel is board certified in Urology.

Dr. Hearn is an Associate Professor in the Department of Radiation Oncology at the University of Michigan. He completed his medical training at Harvard Medical School and his residency in radiation oncology at Cleveland Clinic. Dr. Hearn investigates mechanisms by which prostate cancer may become resistant to current treatments.Dr. Hearn also treats bladder cancer and has been impressed by the promising responses (sometimes dramatic and long-lasting) that some patients with bladder cancer have when treated with immunotherapy to harness the body’s immune system. He is interested in the intersection of immunotherapy and radiation therapy.Additionally, Dr. Hearn is interested in novel techniques to improve the safety and efficacy of radiation therapy for lung cancer by modulating cytokines relevant to lung injury. Dr. Hearn is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, Muscle Invasive Bladder Cancer, and Prostatectomy. Dr. Hearn is board certified in Radiation Oncology.

Joshua Kaplan is a Urologist practicing medicine in Ann Arbor, Michigan. Dr. Kaplan is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Obstructive Uropathy, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Kaplan is board certified in Urology.

Dr. Palmbos received his bachelor’s degree from Calvin College in Grand Rapids, Michigan where he graduated with honors in 2000. He completed his combined M.D. and Ph.D. degrees as part of a NIH sponsored medical scientist training program at the University of Michigan Medical School in Ann Arbor, Michigan in 2008. His graduate work focused on the nonhomologous endjoining pathway of DNA double strand break repair. He then completed his Internal Medicine Residency and Hematology/Oncology Fellowship at the University of Michigan in 2010 and 2014 respectively. His clinical interest is genitourinary malignancies and he primarily sees patients with bladder and prostate cancers. His laboratory research focus is on bladder cancer and he is currently developing new preclinical models of bladder cancer and focusing on the role of a novel oncogene, ATDC, in bladder tumor development. He recently received American Society of Clinical Oncology (ASCO) Young Investigator and Bladder Cancer Advocacy Network (BCAN) Young Investigator awards and has an NIH K08 award to develop his research program. Dr. Palmbos is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Prostate Cancer, Familial Prostate Cancer, and Urothelial Cancer. Dr. Palmbos is board certified in Internal Medicine and Medical Oncology.

Jessica Fried is a Radiologist and an Interventional Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Fried is rated as an Advanced provider by MediFind in the treatment of Prostate Cancer. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Visceromegaly, Alcoholic Cirrhosis, Cholangiocarcinoma (Bile Duct Cancer), and Cirrhosis. Dr. Fried is board certified in Diagnostic Radiology.

James Montie is a Urologist practicing medicine in Ann Arbor, Michigan. Dr. Montie is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Muscle Invasive Bladder Cancer, Bladder Cancer, Prostatectomy, and Cystectomy.

Kassem Faraj is a Urologist practicing medicine in Ann Arbor, Michigan. Dr. Faraj is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy.

Dr. Jackson is an Assistant Professor in the Department of Radiation Oncology at the University of Michigan. He performed his residency in radiation oncology at the University of Michigan, and subsequently joined the faculty upon completion of his training. Within the Department of Radiation Oncology, he serves as the co-Chief of the Genitourinary Radiotherapy Program. Within the Rogel Cancer he is the co-Director of the multidisciplinary Spine Oncology Program.Dr. Jackson’s research focuses mainly on improving outcomes for men with aggressive or recurrent prostate cancer, and he has published extensively on this topic. Dr. Jackson is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Penile Cancer. Dr. Jackson is board certified in Radiation Oncology.

Nitin Ambani is a Urologist practicing medicine in Ann Arbor, Michigan. Dr. Ambani is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and Ureteroscopy.

John Stoffel is a General Surgeon and a Urologist practicing medicine in Ann Arbor, Michigan. Dr. Stoffel is rated as an Experienced provider by MediFind in the treatment of Prostate Cancer. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Neurogenic Bladder, Urinary Incontinence, Urinary Tract Infection (UTI), Reconstructive Urology Surgery, and Hernia Surgery. Dr. Stoffel is board certified in Urology and Female Pelvic Medicine & Reconstructive Surg.